Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Artificial Blood Cells Market Insights, Forecast to 2030

Global Artificial Blood Cells Market Insights, Forecast to 2030

Industry: Medical Devices & Consumables

Published Date: 2024-04-12

Pages: 107 Pages

Report ld: 2936390

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.

The global Artificial Blood Cells market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Covers:

This report presents an overview of global market for Artificial Blood Cells, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Artificial Blood Cells, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Artificial Blood Cells, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Blood Cells sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Blood Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Blood Cells sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others

Segment by Application

Cardiovascular Diseases
Anemia
Organ Transplant
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Artificial Blood Cells in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Artificial Blood Cells manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Blood Cells sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Artificial Blood Cells Product Introduction

1.2 Market by Type

1.2.1 Global Artificial Blood Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Animal Hemoglobin

1.2.3 Human Hemoglobin

1.2.4 Stem Cell

1.2.5 Others

1.3 Market by Application

1.3.1 Global Artificial Blood Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cardiovascular Diseases

1.3.3 Anemia

1.3.4 Organ Transplant

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Artificial Blood Cells Sales Estimates and Forecasts 2019-2030

2.2 Global Artificial Blood Cells Revenue by Region

2.2.1 Global Artificial Blood Cells Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Artificial Blood Cells Revenue by Region (2019-2024)

2.2.3 Global Artificial Blood Cells Revenue by Region (2025-2030)

2.2.4 Global Artificial Blood Cells Revenue Market Share by Region (2019-2030)

2.3 Global Artificial Blood Cells Sales Estimates and Forecasts 2019-2030

2.4 Global Artificial Blood Cells Sales by Region

2.4.1 Global Artificial Blood Cells Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Artificial Blood Cells Sales by Region (2019-2024)

2.4.3 Global Artificial Blood Cells Sales by Region (2025-2030)

2.4.4 Global Artificial Blood Cells Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Artificial Blood Cells Sales by Manufacturers

3.1.1 Global Artificial Blood Cells Sales by Manufacturers (2019-2024)

3.1.2 Global Artificial Blood Cells Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artificial Blood Cells in 2023

3.2 Global Artificial Blood Cells Revenue by Manufacturers

3.2.1 Global Artificial Blood Cells Revenue by Manufacturers (2019-2024)

3.2.2 Global Artificial Blood Cells Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Artificial Blood Cells Revenue in 2023

3.3 Global Key Players of Artificial Blood Cells, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Artificial Blood Cells Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Artificial Blood Cells, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Artificial Blood Cells, Product Offered and Application

3.8 Global Key Manufacturers of Artificial Blood Cells, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Artificial Blood Cells Sales by Type

4.1.1 Global Artificial Blood Cells Historical Sales by Type (2019-2024)

4.1.2 Global Artificial Blood Cells Forecasted Sales by Type (2025-2030)

4.1.3 Global Artificial Blood Cells Sales Market Share by Type (2019-2030)

4.2 Global Artificial Blood Cells Revenue by Type

4.2.1 Global Artificial Blood Cells Historical Revenue by Type (2019-2024)

4.2.2 Global Artificial Blood Cells Forecasted Revenue by Type (2025-2030)

4.2.3 Global Artificial Blood Cells Revenue Market Share by Type (2019-2030)

4.3 Global Artificial Blood Cells Price by Type

4.3.1 Global Artificial Blood Cells Price by Type (2019-2024)

4.3.2 Global Artificial Blood Cells Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Artificial Blood Cells Sales by Application

5.1.1 Global Artificial Blood Cells Historical Sales by Application (2019-2024)

5.1.2 Global Artificial Blood Cells Forecasted Sales by Application (2025-2030)

5.1.3 Global Artificial Blood Cells Sales Market Share by Application (2019-2030)

5.2 Global Artificial Blood Cells Revenue by Application

5.2.1 Global Artificial Blood Cells Historical Revenue by Application (2019-2024)

5.2.2 Global Artificial Blood Cells Forecasted Revenue by Application (2025-2030)

5.2.3 Global Artificial Blood Cells Revenue Market Share by Application (2019-2030)

5.3 Global Artificial Blood Cells Price by Application

5.3.1 Global Artificial Blood Cells Price by Application (2019-2024)

5.3.2 Global Artificial Blood Cells Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Artificial Blood Cells Market Size by Type

6.1.1 US & Canada Artificial Blood Cells Sales by Type (2019-2030)

6.1.2 US & Canada Artificial Blood Cells Revenue by Type (2019-2030)

6.2 US & Canada Artificial Blood Cells Market Size by Application

6.2.1 US & Canada Artificial Blood Cells Sales by Application (2019-2030)

6.2.2 US & Canada Artificial Blood Cells Revenue by Application (2019-2030)

6.3 US & Canada Artificial Blood Cells Market Size by Country

6.3.1 US & Canada Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Artificial Blood Cells Sales by Country (2019-2030)

6.3.3 US & Canada Artificial Blood Cells Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Artificial Blood Cells Market Size by Type

7.1.1 Europe Artificial Blood Cells Sales by Type (2019-2030)

7.1.2 Europe Artificial Blood Cells Revenue by Type (2019-2030)

7.2 Europe Artificial Blood Cells Market Size by Application

7.2.1 Europe Artificial Blood Cells Sales by Application (2019-2030)

7.2.2 Europe Artificial Blood Cells Revenue by Application (2019-2030)

7.3 Europe Artificial Blood Cells Market Size by Country

7.3.1 Europe Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Artificial Blood Cells Sales by Country (2019-2030)

7.3.3 Europe Artificial Blood Cells Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Artificial Blood Cells Market Size

8.1.1 China Artificial Blood Cells Sales (2019-2030)

8.1.2 China Artificial Blood Cells Revenue (2019-2030)

8.2 China Artificial Blood Cells Market Size by Application

8.2.1 China Artificial Blood Cells Sales by Application (2019-2030)

8.2.2 China Artificial Blood Cells Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Artificial Blood Cells Market Size by Type

9.1.1 Asia Artificial Blood Cells Sales by Type (2019-2030)

9.1.2 Asia Artificial Blood Cells Revenue by Type (2019-2030)

9.2 Asia Artificial Blood Cells Market Size by Application

9.2.1 Asia Artificial Blood Cells Sales by Application (2019-2030)

9.2.2 Asia Artificial Blood Cells Revenue by Application (2019-2030)

9.3 Asia Artificial Blood Cells Sales by Region

9.3.1 Asia Artificial Blood Cells Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Artificial Blood Cells Revenue by Region (2019-2030)

9.3.3 Asia Artificial Blood Cells Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Artificial Blood Cells Market Size by Type

10.1.1 Middle East, Africa and Latin America Artificial Blood Cells Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Artificial Blood Cells Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Artificial Blood Cells Market Size by Application

10.2.1 Middle East, Africa and Latin America Artificial Blood Cells Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Artificial Blood Cells Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Artificial Blood Cells Sales by Country

10.3.1 Middle East, Africa and Latin America Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Artificial Blood Cells Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Artificial Blood Cells Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Dextro-Sang Corporation

11.1.1 Dextro-Sang Corporation Company Information

11.1.2 Dextro-Sang Corporation Overview

11.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Dextro-Sang Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Dextro-Sang Corporation Recent Developments

11.2 BioPure Corporation

11.2.1 BioPure Corporation Company Information

11.2.2 BioPure Corporation Overview

11.2.3 BioPure Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 BioPure Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 BioPure Corporation Recent Developments

11.3 Sangart

11.3.1 Sangart Company Information

11.3.2 Sangart Overview

11.3.3 Sangart Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Sangart Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Sangart Recent Developments

11.4 Northfield Laboratories

11.4.1 Northfield Laboratories Company Information

11.4.2 Northfield Laboratories Overview

11.4.3 Northfield Laboratories Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Northfield Laboratories Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Northfield Laboratories Recent Developments

11.5 Baxter International

11.5.1 Baxter International Company Information

11.5.2 Baxter International Overview

11.5.3 Baxter International Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Baxter International Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Baxter International Recent Developments

11.6 Dentritech

11.6.1 Dentritech Company Information

11.6.2 Dentritech Overview

11.6.3 Dentritech Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Dentritech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Dentritech Recent Developments

11.7 FluorO2 Therapeutics

11.7.1 FluorO2 Therapeutics Company Information

11.7.2 FluorO2 Therapeutics Overview

11.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 FluorO2 Therapeutics Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 FluorO2 Therapeutics Recent Developments

11.8 Nuvox Pharma

11.8.1 Nuvox Pharma Company Information

11.8.2 Nuvox Pharma Overview

11.8.3 Nuvox Pharma Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Nuvox Pharma Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Nuvox Pharma Recent Developments

11.9 Alpha Therapeutic Corporation

11.9.1 Alpha Therapeutic Corporation Company Information

11.9.2 Alpha Therapeutic Corporation Overview

11.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Alpha Therapeutic Corporation Recent Developments

11.10 HemoBioTech

11.10.1 HemoBioTech Company Information

11.10.2 HemoBioTech Overview

11.10.3 HemoBioTech Artificial Blood Cells Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 HemoBioTech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 HemoBioTech Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Artificial Blood Cells Industry Chain Analysis

12.2 Artificial Blood Cells Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Artificial Blood Cells Production Mode & Process

12.4 Artificial Blood Cells Sales and Marketing

12.4.1 Artificial Blood Cells Sales Channels

12.4.2 Artificial Blood Cells Distributors

12.5 Artificial Blood Cells Customers

13 Market Dynamics

13.1 Artificial Blood Cells Industry Trends

13.2 Artificial Blood Cells Market Drivers

13.3 Artificial Blood Cells Market Challenges

13.4 Artificial Blood Cells Market Restraints

14 Key Findings in The Global Artificial Blood Cells Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Artificial Blood Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Animal Hemoglobin

Table 3. Major Manufacturers of Human Hemoglobin

Table 4. Major Manufacturers of Stem Cell

Table 5. Major Manufacturers of Others

Table 6. Global Artificial Blood Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Artificial Blood Cells Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Artificial Blood Cells Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Artificial Blood Cells Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Artificial Blood Cells Revenue Market Share by Region (2019-2024)

Table 11. Global Artificial Blood Cells Revenue Market Share by Region (2025-2030)

Table 12. Global Artificial Blood Cells Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Artificial Blood Cells Sales by Region (2019-2024) & (K Units)

Table 14. Global Artificial Blood Cells Sales by Region (2025-2030) & (K Units)

Table 15. Global Artificial Blood Cells Sales Market Share by Region (2019-2024)

Table 16. Global Artificial Blood Cells Sales Market Share by Region (2025-2030)

Table 17. Global Artificial Blood Cells Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Artificial Blood Cells Sales Share by Manufacturers (2019-2024)

Table 19. Global Artificial Blood Cells Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Artificial Blood Cells Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Artificial Blood Cells, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Artificial Blood Cells Price by Manufacturers 2019-2024 (US$/Unit)

Table 23. Global Artificial Blood Cells Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Artificial Blood Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2023)

Table 25. Global Key Manufacturers of Artificial Blood Cells, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Artificial Blood Cells, Product Offered and Application

Table 27. Global Key Manufacturers of Artificial Blood Cells, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 30. Global Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 31. Global Artificial Blood Cells Sales Share by Type (2019-2024)

Table 32. Global Artificial Blood Cells Sales Share by Type (2025-2030)

Table 33. Global Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Artificial Blood Cells Revenue Share by Type (2019-2024)

Table 36. Global Artificial Blood Cells Revenue Share by Type (2025-2030)

Table 37. Artificial Blood Cells Price by Type (2019-2024) & (US$/Unit)

Table 38. Global Artificial Blood Cells Price Forecast by Type (2025-2030) & (US$/Unit)

Table 39. Global Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 40. Global Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 41. Global Artificial Blood Cells Sales Share by Application (2019-2024)

Table 42. Global Artificial Blood Cells Sales Share by Application (2025-2030)

Table 43. Global Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Artificial Blood Cells Revenue Share by Application (2019-2024)

Table 46. Global Artificial Blood Cells Revenue Share by Application (2025-2030)

Table 47. Artificial Blood Cells Price by Application (2019-2024) & (US$/Unit)

Table 48. Global Artificial Blood Cells Price Forecast by Application (2025-2030) & (US$/Unit)

Table 49. US & Canada Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Artificial Blood Cells Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Artificial Blood Cells Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Artificial Blood Cells Sales by Country (2025-2030) & (K Units)

Table 62. Europe Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 63. Europe Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 64. Europe Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 67. Europe Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 68. Europe Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Artificial Blood Cells Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Artificial Blood Cells Sales by Country (2019-2024) & (K Units)

Table 74. Europe Artificial Blood Cells Sales by Country (2025-2030) & (K Units)

Table 75. China Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 76. China Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 77. China Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 80. China Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 81. China Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 84. Asia Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 85. Asia Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 88. Asia Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 89. Asia Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Artificial Blood Cells Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Artificial Blood Cells Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Artificial Blood Cells Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Artificial Blood Cells Sales by Region (2019-2024) & (K Units)

Table 95. Asia Artificial Blood Cells Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Artificial Blood Cells Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Artificial Blood Cells Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Artificial Blood Cells Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Artificial Blood Cells Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Artificial Blood Cells Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Artificial Blood Cells Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Artificial Blood Cells Sales by Country (2025-2030) & (K Units)

Table 109. Dextro-Sang Corporation Company Information

Table 110. Dextro-Sang Corporation Description and Major Businesses

Table 111. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 112. Dextro-Sang Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Dextro-Sang Corporation Recent Developments

Table 114. BioPure Corporation Company Information

Table 115. BioPure Corporation Description and Major Businesses

Table 116. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 117. BioPure Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. BioPure Corporation Recent Developments

Table 119. Sangart Company Information

Table 120. Sangart Description and Major Businesses

Table 121. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 122. Sangart Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Sangart Recent Developments

Table 124. Northfield Laboratories Company Information

Table 125. Northfield Laboratories Description and Major Businesses

Table 126. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 127. Northfield Laboratories Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Northfield Laboratories Recent Developments

Table 129. Baxter International Company Information

Table 130. Baxter International Description and Major Businesses

Table 131. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 132. Baxter International Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Baxter International Recent Developments

Table 134. Dentritech Company Information

Table 135. Dentritech Description and Major Businesses

Table 136. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 137. Dentritech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Dentritech Recent Developments

Table 139. FluorO2 Therapeutics Company Information

Table 140. FluorO2 Therapeutics Description and Major Businesses

Table 141. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 142. FluorO2 Therapeutics Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. FluorO2 Therapeutics Recent Developments

Table 144. Nuvox Pharma Company Information

Table 145. Nuvox Pharma Description and Major Businesses

Table 146. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 147. Nuvox Pharma Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Nuvox Pharma Recent Developments

Table 149. Alpha Therapeutic Corporation Company Information

Table 150. Alpha Therapeutic Corporation Description and Major Businesses

Table 151. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 152. Alpha Therapeutic Corporation Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Alpha Therapeutic Corporation Recent Developments

Table 154. HemoBioTech Company Information

Table 155. HemoBioTech Description and Major Businesses

Table 156. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 157. HemoBioTech Artificial Blood Cells Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. HemoBioTech Recent Developments

Table 159. Key Raw Materials Lists

Table 160. Raw Materials Key Suppliers Lists

Table 161. Artificial Blood Cells Distributors List

Table 162. Artificial Blood Cells Customers List

Table 163. Artificial Blood Cells Market Trends

Table 164. Artificial Blood Cells Market Drivers

Table 165. Artificial Blood Cells Market Challenges

Table 166. Artificial Blood Cells Market Restraints

Table 167. Research Programs/Design for This Report

Table 168. Key Data Information from Secondary Sources

Table 169. Key Data Information from Primary Sources

List of Figures

Figure 1. Artificial Blood Cells Product Picture

Figure 2. Global Artificial Blood Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Artificial Blood Cells Market Share by Type in 2023 & 2030

Figure 4. Animal Hemoglobin Product Picture

Figure 5. Human Hemoglobin Product Picture

Figure 6. Stem Cell Product Picture

Figure 7. Others Product Picture

Figure 8. Global Artificial Blood Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Artificial Blood Cells Market Share by Application in 2023 & 2030

Figure 10. Cardiovascular Diseases

Figure 11. Anemia

Figure 12. Organ Transplant

Figure 13. Others

Figure 14. Artificial Blood Cells Report Years Considered

Figure 15. Global Artificial Blood Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Artificial Blood Cells Revenue 2019-2030 (US$ Million)

Figure 17. Global Artificial Blood Cells Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Artificial Blood Cells Revenue Market Share by Region (2019-2030)

Figure 19. Global Artificial Blood Cells Sales 2019-2030 ((K Units)

Figure 20. Global Artificial Blood Cells Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Artificial Blood Cells Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Artificial Blood Cells Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Artificial Blood Cells Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Artificial Blood Cells Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Artificial Blood Cells Sales YoY (2019-2030) & (K Units)

Figure 26. China Artificial Blood Cells Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Artificial Blood Cells Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Artificial Blood Cells Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Artificial Blood Cells Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Artificial Blood Cells Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Artificial Blood Cells Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Artificial Blood Cells in the World: Market Share by Artificial Blood Cells Revenue in 2023

Figure 33. Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 35. Global Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 36. Global Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 37. Global Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Artificial Blood Cells Revenue Share by Country (2019-2030)

Figure 43. US & Canada Artificial Blood Cells Sales Share by Country (2019-2030)

Figure 44. U.S. Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 47. Europe Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 48. Europe Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 49. Europe Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 50. Europe Artificial Blood Cells Revenue Share by Country (2019-2030)

Figure 51. Europe Artificial Blood Cells Sales Share by Country (2019-2030)

Figure 52. Germany Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 53. France Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 57. China Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 58. China Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 59. China Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 60. China Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 61. Asia Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 62. Asia Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 63. Asia Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 64. Asia Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 65. Asia Artificial Blood Cells Revenue Share by Region (2019-2030)

Figure 66. Asia Artificial Blood Cells Sales Share by Region (2019-2030)

Figure 67. Japan Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 71. India Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Artificial Blood Cells Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Artificial Blood Cells Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Artificial Blood Cells Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Artificial Blood Cells Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Artificial Blood Cells Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Artificial Blood Cells Sales Share by Country (2019-2030)

Figure 78. Brazil Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Artificial Blood Cells Revenue (2019-2030) & (US$ Million)

Figure 83. Artificial Blood Cells Value Chain

Figure 84. Artificial Blood Cells Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Artificial Blood Cells market? zhanKai

The top companies in the global Artificial Blood Cells market are Dextro-Sang Corporation、BioPure Corporation、Sangart.

Related Reports

Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 134
USD 3950.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2026
The global Artificial Blood Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 114
USD 2900.00
(Single User License)
Global Artificial Blood Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Blood Cells market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Artificial Blood Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Blood Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 131
USD 4900.00
(Single User License)
Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 92
USD 3950.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2025
The global market for Artificial Blood Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 82
USD 2900.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2024
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
Artificial Blood Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published Date: 2024-01-10
Pages: 128
USD 3950.00
(Single User License)

Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 134
USD 3950.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2026
The global Artificial Blood Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 114
USD 2900.00 (Single User License)
Global Artificial Blood Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Blood Cells market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)
Global Artificial Blood Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Blood Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 131
USD 4900.00 (Single User License)
Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 92
USD 3950.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2025
The global market for Artificial Blood Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 82
USD 2900.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2024
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)
Artificial Blood Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published: 2024-01-10
Pages: 128
USD 3950.00 (Single User License)